| Alexander Horne, | |
|
2825 Stockyard Rd Ste I-200, Missoula, MT 59808-1548 | |
| (406) 728-8420 | |
| (406) 541-8430 |
| Full Name | Alexander Horne |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 10 Years |
| Location | 2825 Stockyard Rd Ste I-200, Missoula, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679983456 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Patrick Hospital | Missoula, MT | Hospital |
| Community Medical Center | Missoula, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Missoula Anesthesiology Pc | 5597669960 | 48 |
News Archive
A breakthrough using cutting-edge stem cell research could speed up the discovery of new treatments for motor neurone disease (MND).
A long-time aim of obstetrical research has been to find agents that could delay or diminish pre-term labor because even today pre-term birth is a leading cause of infant mortality and morbidity.
Oncothyreon Inc. today announced that Merck KGaA of Darmstadt, Germany, has initiated a Phase 3 trial of Stimuvax(R) (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer (NSCLC). The trial, named INSPIRE (Stimuvax trial In Asian NSCLC Patients: Stimulating Immune Response), is anticipated to enroll approximately 420 patients in China, Hong Kong, South Korea, Singapore and Taiwan.
Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which Boston Scientific will acquire Sadra Medical, Inc., a development-stage company in Los Gatos, California. Sadra is developing the first fully repositionable device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis.
Celldex Therapeutics, Inc. today announced that the first patient has been screened in a randomized Phase 2 study of the Company's novel, first-in-class antibody-based vaccine candidate from its Precision Targeted Immunotherapy (PTI) platform. This study will evaluate the CDX-1307 regimen in both neoadjuvant and adjuvant settings in patients with newly diagnosed muscle-invasive bladder cancers that express hCG-beta.
› Verified 4 days ago
| Entity Name | Missoula Anesthesiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710931225 PECOS PAC ID: 5597669960 Enrollment ID: O20040324001699 |
News Archive
A breakthrough using cutting-edge stem cell research could speed up the discovery of new treatments for motor neurone disease (MND).
A long-time aim of obstetrical research has been to find agents that could delay or diminish pre-term labor because even today pre-term birth is a leading cause of infant mortality and morbidity.
Oncothyreon Inc. today announced that Merck KGaA of Darmstadt, Germany, has initiated a Phase 3 trial of Stimuvax(R) (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer (NSCLC). The trial, named INSPIRE (Stimuvax trial In Asian NSCLC Patients: Stimulating Immune Response), is anticipated to enroll approximately 420 patients in China, Hong Kong, South Korea, Singapore and Taiwan.
Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which Boston Scientific will acquire Sadra Medical, Inc., a development-stage company in Los Gatos, California. Sadra is developing the first fully repositionable device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis.
Celldex Therapeutics, Inc. today announced that the first patient has been screened in a randomized Phase 2 study of the Company's novel, first-in-class antibody-based vaccine candidate from its Precision Targeted Immunotherapy (PTI) platform. This study will evaluate the CDX-1307 regimen in both neoadjuvant and adjuvant settings in patients with newly diagnosed muscle-invasive bladder cancers that express hCG-beta.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexander Horne, 430 Eudora St, Denver, CO 80220-5127 Ph: () - | Alexander Horne, 2825 Stockyard Rd Ste I-200, Missoula, MT 59808-1548 Ph: (406) 728-8420 |
News Archive
A breakthrough using cutting-edge stem cell research could speed up the discovery of new treatments for motor neurone disease (MND).
A long-time aim of obstetrical research has been to find agents that could delay or diminish pre-term labor because even today pre-term birth is a leading cause of infant mortality and morbidity.
Oncothyreon Inc. today announced that Merck KGaA of Darmstadt, Germany, has initiated a Phase 3 trial of Stimuvax(R) (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer (NSCLC). The trial, named INSPIRE (Stimuvax trial In Asian NSCLC Patients: Stimulating Immune Response), is anticipated to enroll approximately 420 patients in China, Hong Kong, South Korea, Singapore and Taiwan.
Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which Boston Scientific will acquire Sadra Medical, Inc., a development-stage company in Los Gatos, California. Sadra is developing the first fully repositionable device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis.
Celldex Therapeutics, Inc. today announced that the first patient has been screened in a randomized Phase 2 study of the Company's novel, first-in-class antibody-based vaccine candidate from its Precision Targeted Immunotherapy (PTI) platform. This study will evaluate the CDX-1307 regimen in both neoadjuvant and adjuvant settings in patients with newly diagnosed muscle-invasive bladder cancers that express hCG-beta.
› Verified 4 days ago
August Denicco, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2825 Stockyard Rd Ste I-200, Missoula, MT 59808 Phone: 406-728-8420 Fax: 406-541-8430 | |
Teresa Ann Garland, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3550 Mullan Rd, Suite 103, Missoula, MT 59808 Phone: 406-728-8420 | |
Alistair James Macdonald, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3550 Mullan Rd, Suite 103, Missoula, MT 59808 Phone: 406-728-8420 | |
Bruce Allen Bollen, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3550 Mullan Rd, Suite 103, Missoula, MT 59808 Phone: 406-728-8420 | |
John Kirkeide, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 3550 Mullan Rd, Suite 103, Missoula, MT 59808 Phone: 406-728-8420 | |
Jason B. Tingey, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2825 Stockyard Rd, Bldg I-200, Missoula, MT 59808 Phone: 406-728-8420 Fax: 406-541-8430 | |
Cordel A Anderson, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2825 Stockyard Rd, Bldg I-200, Missoula, MT 59808 Phone: 406-728-8420 Fax: 406-541-8430 |